Health
Key biomarker for inflammation and COVID-19 risk – Medical Xpress
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage…
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
In a new paper in International Journal of Infectious Diseases, medical experts in Italy and Australia examined levels of a chemical called serum amyloid A (SAA), a protein synthesized in the liver which can spike up to 1,000-fold within the first 24-48 hours of an infection.
…
-
Noosa News23 hours agoUnderstanding the conflict conundrum – Proctor
-
Noosa News23 hours agoQld CFMEU labels David Crisafulli’s vow to rid state of union ‘offensive and dangerous’
-
Business22 hours ago9 ASX shares including Nuix and PolyNovo dumped from ASX 200
-
Noosa News23 hours agoThree Bartender-Approved Peanut Butter Whisky Cocktails